Clinical Trial Categories
Myelofribrosis Trials
Trial ID 20346
NCT04562870clinicaltrials.gov ID
USOR ID: 20346
Phase II
A PHASE 2, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF SINGLE AGENT SELINEXOR VERSUS TREATMENT OF PHYSICIANíS CHOICE IN PATIENTS WITH PREVIOUSLY TREATED MYELOFIBROSIS (XPORT-MF-035)
Trial ID 20177
NCT04472598clinicaltrials.gov ID
USOR ID: 20177
Phase III
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Navitoclax in Combination with Ruxolitinib versus Ruxolitinib in Subjects with Myelofibrosis (TRANSFORM-1)
